Jinxuan Hou

Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer

Lanxiang Huang, Yuan Rong, Xuan Tang et al. · Molecular Cancer · 2022 · 363 citations · Full text

Vandetanib in metastatic hereditary medullary thyroid cancer: Follow-up results of an open-label phase II trial

Samuel A. Wells, Jessica E. Gosnell, Robert F. Gagel et al. · Journal of Clinical Oncology · 2007 · 91 citations

Surgical Oncology, Pathology, Follow-up Results +17

Functional proteomic analysis reveals the involvement of KIAA1199 in breast cancer growth, motility and invasiveness

Mohammad‐Saeid Jami, Jinxuan Hou, Miao Liu et al. · BMC Cancer · 2014 · 76 citations · Full text

Long noncoding RNA HULC promotes colorectal carcinoma progression through epigenetically repressing NKD2 expression

Xiaojun Yang, Chaoqun Huang, Chun‐Wei Peng et al. · Gene · 2016 · 68 citations

Tumor Biology, Medicine, Colorectal Cancer +9

Co-expression network analysis identified candidate biomarkers in association with progression and prognosis of breast cancer

Qiang Zhou, Jiangbo Ren, Jinxuan Hou et al. · Journal of Cancer Research and Clinical Oncology · 2019 · 67 citations · Full text

Prognostic Biomarkers, Breast Oncology, Engineering +13